News
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...
Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...
According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.
Many pharmaceutical products made in Europe will face a 15 percent tariff, pinching manufacturers and potentially leading to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback